PATENT CLAIM ANALYSIS

Application Number: 16418265
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["514", "003700"]

Abstract:
Described is a composition comprising a peptide which consists of 7-17 adjacent amino acids and comprises the hexamer TX 1 EX 2 X 3 E, where X 1 , X 2 , and X 3  can be any natural or non-natural amino acid, and the peptide is cyclized and does not exhibit TNF receptor binding activity, and an inhibitor of viral neuraminidase.

Claim (Index 21):
The composition of  claim 20 , wherein the pharmaceutically acceptable carrier is selected from the group consisting of water, sodium chloride, sodium phosphate, sodium acetate, sodium carbonate, citrate, glycine, glycylglycine, histidine, lysine, arginine, TRIS, sodium citrate, Ringer's solution, dextrose, mannite, trehalose, saccharose, sorbite, fructose, maltose, lactose or dextrane, Hank's solution, fixed oils, ethyl oleate, stabilizing agents, pharmaceutically acceptable proteins, polysaccharides, polylactic acids, polyglycolic acids, polymeric amino acids and amino acid copolymers.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.43478
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13885705', '14434328', '13321460', '12269781', '12726297']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7622725230695419
- 35 USC 102 Novelty (BERT): 0.5756172965006621
- Combined Prediction Score: 0.7436070004126539
- Mean Citation Score: 294.6024000000001
- Max Citation Score: 465.86453
- Similarity Product: 388.2166837726438

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test